DELFI Diagnostics is a medical and diagnostic laboratory company headquartered in Palo Alto, California, focused on developing advanced blood-based liquid biopsy tests for early cancer detection.
Subscribe to see Delfi Limited’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A few of Delfi Limited's closest competitors — see the full list of competitors and alternatives →
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics using its Polaris discovery platform. The company is headquartered in Berlin, Germany.
Doc.ai, Inc. is a health care company located in Palo Alto, California, specializing in artificial intelligence, blockchain, and clinical trials research.
Huma.AI, Inc. is a technology company headquartered in Palo Alto, California, that positions itself at the intersection of artificial intelligence and practical value for Medical Affairs.
DeepRadiology Corp develops artificial intelligence and deep learning algorithms to analyze medical imaging modalities such as CT scans, X-rays, and mammography. The company serves healthcare facilities, including hospitals, trauma centers, and outpatient imaging centers, to optimize their diagnostic services.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.